Huapont Life Science Co., Ltd.

Huapont Life Science Co., Ltd., founded in 1992, is a prominent company in the field of skin clinical medicine and skin health in China. Listed on the Shenzhen Stock Exchange in 2004, the company has developed a comprehensive business model that spans various sectors, including medicine, medical treatment, agricultural chemicals, new materials, and tourism. Headquartered in Liangjiang New Area of Chongqing, Huapont operates over 100 holding companies across multiple provinces and internationally, employing more than 12,000 individuals and distributing products to 58 countries and regions. The company's core business focuses on pharmaceuticals and medical treatments, particularly in the skin health sector, where it has established itself as a leading enterprise. Huapont has developed an integrated model encompassing research, production, and marketing, addressing diverse customer needs in skin treatment. In addition to its hospital market presence, the company is expanding into the medical beauty consumer market. It operates five hospitals and is dedicated to building a first-class private medical service brand in China, leveraging its research and development capabilities to enhance its market position.

The company continues to promote the "big health" development strategy, and the business structure is further clear. The core business, led by medicine and medical treatment, has maintained steady growth and high-quality development. Agricultural chemicals, new materials, tourism and other businesses have been separated and listed and operated independently. The company has been deeply engaged in the skin pharmaceutical industry for nearly 30 years, and is a leading enterprise in the field of skin clinical medicine and skin health in China. It has established an integrated business model of research, production and marketing from the front-end API to the back-end preparation. The company has a complete medical product echelon and extensive coverage, which can meet the comprehensive and multi-level needs of skin treatment of customers of all ages. While consolidating the leading position in the hospital market, the company actively uses its r&d and channel advantages to enhance the market share outside the hospital, and further expands its business scope to the medical beauty consumer market. The company's total operating 5 hospitals, comprehensive health care, rehabilitation, slow disease management, medical and other fields, the company in chongqing north forgiveness hospital as the core, give full play to the synergistic effect at home and abroad, and gradually establish a winbond health characteristic of medical service system, and is committed to become China's first-class private medical service brand.